{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "populationDescription": "The Screened Set includes all participants who signed an informed consent form (ICF)."
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "populationDescription": "The Enrolled Set includes all participants who were enrolled in the study."
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FAS",
        "populationDescription": "The Full Analysis Set (FAS) includes all participants who were enrolled in the study and received at least 1 dose of study drug. The FAS will be the primary analysis set for all efficacy analyses."
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "populationDescription": "The Per Protocol (PP) Set includes all participants in the FAS who do not have any major protocol deviations that would impact the interpretability of the efficacy data. Major protocol deviations will be identified and documented before database lock. The PP Set will be used for sensitivity analyses of the primary efficacy endpoint."
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "SAF",
        "populationDescription": "The Safety Set includes all participants who received at least 1 dose of study drug. All safety analyses will be performed using the Safety Set."
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "populationType": "PK/PD",
        "instanceType": "AnalysisPopulation",
        "label": "PK Set",
        "populationDescription": "The Pharmacokinetic (PK) Analysis Set (PK Set) includes all participants in the Safety Set who have sufficient plasma concentration data to allow for the derivation of at least 1 PK parameter. The PK Set will be used for all PK analyses."
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "populationType": "PK/PD",
        "instanceType": "AnalysisPopulation",
        "label": "PD Set",
        "populationDescription": "The Pharmacodynamic (PD) Analysis Set (PD Set) includes all participants in the Safety Set who have sufficient PD data to allow for the derivation of at least 1 PD parameter. The PD Set will be used for all PD analyses."
      }
    ],
    "characteristics": [],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 0
    }
  }
}